Primary Site >> Biliary tract Cancer
Gene >> KIT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Stromal tumor of the gallbladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. PMID: 11023105 |
Ref: Malignant stromal tumor of the gallbladder with interstitial cells of Cajal phenotype. PMID: 11900579 Ref: Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. PMID: 12379757 |
Ref: Expression of Kit and platelet-derived growth factor receptors alpha and beta in cholangiocarcinoma, and case report of therapy with imatinib mesylate (STI571). PMID: 14501388 Ref: Imatinib mesylate (STI571; Glivec)--a new approach in the treatment of biliary tract cancer? PMID: 14551510 Ref: Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. PMID: 14691921 |
Ref: Establishment and characterization of unique human gallbladder cancer cell lines. PMID: 15067341 Ref: Analysis of KIT (CD117) expression in gallbladder carcinomas by tissue microarray. PMID: 15336730 Ref: Malignant gastrointestinal stromal tumor of the gallbladder. PMID: 15483360 Ref: Possible stem cell origin of human cholangiocarcinoma. PMID: 15484322 Ref: Imatinib mesylate induces apoptosis in human cholangiocarcinoma cells. PMID: 15566522 |
Ref: Characterization and genetic analysis in the newly established human bile duct cancer cell lines. PMID: 15645130 Ref: Extramedullary myeloid tumour (EMMT) of the gallbladder. PMID: 15677545 Ref: Hepatocellular progenitor cell tumor of the gallbladder: a case report and review of the literature. PMID: 15696116 Ref: Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: Immunohistochemical evidence. PMID: 15888382 Ref: Prevalence of KIT expression in human tumors: gallbladder cancer. PMID: 16051977 |
Ref: Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype. PMID: 16377099 Ref: Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice. PMID: 16570351 Ref: Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer. PMID: 16708300 Ref: Myeloid sarcoma of the extrahepatic bile ducts presenting as obstructive jaundice. PMID: 16948823 |
Ref: Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. PMID: 18184271 Ref: Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. PMID: 18393293 |
Ref: Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. PMID: 20437099 Ref: A Malignant Gastrointestinal Stromal Tumor of the Gallbladder Immunoreactive for PDGFRA and Negative for CD 117 Antigen (c-KIT). PMID: 21760661 Ref: Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a possible stem cell tumor? PMID: 21951672 Ref: Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma. PMID: 22146626 Ref: Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis. PMID: 22175889 |
Ref: Leiomyoma of the gallbladder in a patient with metastatic gastrointestinal stromal tumor in the liver: A case report with differential diagnostic considerations. PMID: 23226796 |
Ref: Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. PMID: 23388123 Ref: Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. PMID: 23573322 Ref: Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. PMID: 24136146 |
Ref: High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma. PMID: 25245603 Ref: Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme. PMID: 25446376 |
Ref: Pathogenesis of Cholangiolocellular Carcinoma: Possibility of an Interlobular Duct Origin. PMID: 26179521 |
Ref: Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. PMID: 26586401 Ref: Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature. PMID: 27535234 |
Ref: Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components. PMID: 28698100 |
Ref: Screening for key lncRNAs in the progression of gallbladder cancer using bioinformatics analyses. PMID: 29512694 Ref: Evaluation of NCAM and c-Kit as hepatic progenitor cell markers for intrahepatic cholangiocarcinomas. PMID: 30301635 |